Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maralixibat in Cholestatic Pruritus
NCT06553768Phase 3Active, not recruiting
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Start
- Oct 2024
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of maralixibat in cholestatic pruritus, sponsored by Mirum Pharmaceuticals, Inc.. Started Oct 2024; status: active, not recruiting.
02
Drugs
maralixibat
03
Conditions
cholestatic pruritus
Beyond the preview
Go deeper on NCT06553768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06553768.